Preeclampsia is a hypertensive pregnancy disease associated with a massive increase in
sFlt-1 (soluble form of the vascular endothelial growth factor 1) in the maternal circulation …

Background Preeclampsia remains one of the most serious complications of pregnancy.
Effective therapies are yet to be developed. Recent research has identified an imbalance of …

Preeclampsia is a potentially life-threatening multisystem disease affecting 4% to 8% of
pregnant women after the 20th week of gestation. An excess of placental expressed …

Background—Targeted therapies to stabilize the clinical manifestations and prolong
pregnancy in preeclampsia do not exist. Soluble fms-like tyrosine kinase 1 (sFlt-1), an …

Background Preeclampsia is a hypertensive syndrome that complicates 3% to 5% of
pregnancies in the United States. Preeclampsia originates from an improperly vascularized …

J Am Soc Nephrol 27: 657–665, 2016 Editorials 663 www. jasn. org EDITORIALS and
mortality. The general approach of aggressive antenatal surveillance, diagnosis, and …

Abstract Objective: Soluble Fms-like tyrosine kinase-1 (sFlt-1) is thought to be causative in
the pathogenesis of preeclampsia (PE) and specific removal of sFlt-1 via dextran sulfate …

Soluble fms‐like tyrosine kinase‐1 (sFlt1), a circulating vascular endothelial growth factor
receptor 1 antagonist, is associated with the pathogenesis of pre‐eclampsia. Extracorporeal …

Preeclampsia is a devastating complication of pregnancy. Soluble Fms-like tyrosine kinase-
1 (sFlt-1) is an antiangiogenic protein believed to mediate the signs and symptoms of …

Preeclampsia is a pregnancy-related hypertensive disease resulting in substantial maternal
and neonatal morbidity and mortality. Until today there is no satisfactory treatment to stop …